SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-121435
Filing Date
2010-05-17
Accepted
2010-05-17 08:31:28
Documents
4
Period of Report
2010-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 18358
2 OPINION OF PILLSBURY WITHROP SHAW PITTMAN LLP dex51.htm EX-5.1 6611
3 CONTINUOUS OFFERING PROGRAM AGREEMENT DATED MAY 14, 2010 dex101.htm EX-10.1 119991
4 GRAPHIC g98976g30t24.jpg GRAPHIC 1760
  Complete submission text file 0001193125-10-121435.txt   149362
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 10835842
SIC: 2834 Pharmaceutical Preparations